Linked Life Data

9251904

Source:http://linkedlifedata.com/resource/pubmed/id/9251904

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1997-10-2
pubmed:abstractText
1. The renal vasodilatory effect of YM435 was used as an index of its dopamine DA1 receptor agonist activity and compared with that of dopamine in pentobarbital-anesthetized dogs. 2. Intrarenal arterial administration of YM435 (0.1 to 10 micrograms) and dopamine (1 to 100 micrograms) produced a dose-dependent increase in renal blood flow. The doses of YM435 and dopamine required to cause a 30-ml/min increase in renal blood flow were 2.0 and 26.8 micrograms intra-arterially (IA), respectively. YM435 was therefore 13 times more potent than dopamine in this effect. 3. The selective dopamine DA1 receptor antagonist, SCH 23390, but not the selective dopamine DA2 receptor antagonist, nemonapride, caused dose-dependent, parallel shifts to the right in the dose-responsive curve of YM435. 4. The present results demonstrate that YM435 is a potent and selective dopamine DA1 receptor agonist.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0306-3623
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
229-32
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Dopamine DA1 receptor agonist activity of YM435 in the canine renal vasculature.
pubmed:affiliation
Cardiovascular and Atherosclerosis Research Laboratories, Ibaraki, Japan. YATSU@YAMANOUCHI.CO.JP
pubmed:publicationType
Journal Article, Comparative Study